Hikma Pharmaceuticals Aktie
Mit dem Broker, der Top-Insights, geprüfte Analysen
und Trading ab 0 € vereint (zzgl. Spreads).
Hikma Pharmaceuticals Aktie Analyse
| 14.12.12 | Hikma Pharmaceuticals overweight | Morgan Stanley | |
| 15.10.12 | Hikma Pharmaceuticals overweight | J.P. Morgan Cazenove | |
| 10.10.11 | Hikma Pharmaceuticals buy | Citigroup Corp. | |
| 21.07.09 | Hikma Pharmaceuticals | Global Biotech Investing |